Effects of Autologous Bone Marrow Mononuclear Cells Implantation in Canine Model of Pulmonary Hypertension
Authors:
Open Access
- 1 January 2012
- journal article
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 76 (4) , 977-985
Abstract
Background: We investigated the safety and feasibility of intratracheal administration of autologous bone marrow-derived mononuclear cells (ABM-MNCs) and observed the effects in a canine model of pulmonary hypertension (PH). Methods and Results: The PH model was induced by intravenous injection of 3mg/kg dehydromonocrotaline (DMCT) via the right atrium. Two weeks after DMCT administration, the animals received 4 different treatments (n=10 in each group): (I) negative control group; (II): ABM-MNCs group; (III) PH group; (IV) PH+ABM-MNCs group. Six weeks after injection of cells (107), the hemodynamic data were significantly improved in group IV compared with group III (P<0.05). The ratio of right ventricular weight to left ventricular plus septal weight was significantly decreased in group IV compared with group III (P<0.05). The mRNA levels of vascular endothelial growth factor, preproendothelin-1, interleukin-6 and tumor necrosis factor-α were significantly improved in group IV compared with group III (P<0.05). The immunofluorescence result showed that 6 weeks after administration ABM-MNCs could differentiate into pulmonary vascular endothelial cells. Conclusions: Six weeks after intratracheal administration, ABM-MNCs significantly improved the impairment caused by DMCT in a canine model of PH (ie, decreased pulmonary arteriolar narrowing, alveolar septum thickening and right ventricular hypertrophy, enhanced angiogenesis) and this provides a firm foundation for a clinical trial. (Circ J 2012; 76: 977-985)Keywords
This publication has 39 references indexed in Scilit:
- Expression of P2X4R mRNA and Protein in Rats With Hypobaric Hypoxia-Induced Pulmonary HypertensionCirculation Journal, 2011
- Recent Progress in the Management of Pulmonary HypertensionCirculation Journal, 2011
- Enhanced hemostatic indices in patients with pulmonary arterial hypertension: An observational studyThrombosis Research, 2010
- Cellular and Molecular Basis of Pulmonary Arterial HypertensionJACC, 2009
- Molecular mechanisms of pulmonary hypertensionClinica Chimica Acta, 2009
- The Antiproliferative Effect of Sildenafil on Pulmonary Artery Smooth Muscle Cells Is Mediated via Upregulation of Mitogen-Activated Protein Kinase Phosphatase-1 and Degradation of Extracellular Signal-Regulated Kinase 1/2 PhosphorylationAnesthesia & Analgesia, 2007
- Intratracheal mesenchymal stem cell administration attenuates monocrotaline-induced pulmonary hypertension and endothelial dysfunctionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Microvascular Regeneration in Established Pulmonary Hypertension by Angiogenic Gene TransferAmerican Journal of Respiratory Cell and Molecular Biology, 2006
- Implantation of Mesenchymal Stem Cells Overexpressing Endothelial Nitric Oxide Synthase Improves Right Ventricular Impairments Caused by Pulmonary HypertensionCirculation, 2006
- Effect of L-Arginine on Collagen of High Flow-Induced Pulmonary Arterial RemodelingCirculation Journal, 2005